Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:391438.
doi: 10.1155/2012/391438. Epub 2012 Oct 22.

Protein clearance mechanisms of alpha-synuclein and amyloid-Beta in lewy body disorders

Affiliations

Protein clearance mechanisms of alpha-synuclein and amyloid-Beta in lewy body disorders

Michela Deleidi et al. Int J Alzheimers Dis. 2012.

Abstract

Protein clearance is critical for the maintenance of the integrity of neuronal cells, and there is accumulating evidence that in most-if not all-neurodegenerative disorders, impaired protein clearance fundamentally contributes to functional and structural alterations eventually leading to clinical symptoms. Dysfunction of protein clearance leads to intra- and extraneuronal accumulation of misfolded proteins and aggregates. The pathological hallmark of Lewy body disorders (LBDs) is the abnormal accumulation of misfolded proteins such as alpha-synuclein (Asyn) and amyloid-beta (Abeta) in a specific subset of neurons, which in turn has been related to deficits in protein clearance. In this paper we will highlight common intraneuronal (including autophagy and unfolded protein stress response) and extraneuronal (including interaction of neurons with astrocytes and microglia, phagocytic clearance, autoimmunity, cerebrospinal fluid transport, and transport across the blood-brain barrier) protein clearance mechanisms, which may be altered across the spectrum of LBDs. A better understanding of the pathways underlying protein clearance-in particular of Asyn and Abeta-in LBDs may result in the identification of novel biomarkers for disease onset and progression and of new therapeutic targets.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Intra- and extraneuronal mechanisms of protein clearance. The main intracellular pathways for the degradation and recycling of proteins are the ubiquitin/proteasome system (UPS) and the autophagy-lysosomal pathway (microautophagy, macroautophagy, and chaperone-mediated autophagy (CMA)). Extracellular clearance pathways include interaction of neurons with astro- and microglia, and with infiltrating macrophages, autoantibodies, and protein transport from the parenchyma to the cerebrospinal fluid and across the blood-brain barrier. The engulfment of misfolded proteins by astro- and microglia triggers the release of proinflammatory cytokines and chemokines as well as reactive oxygen/nitrogen species, which may, under pathological conditions, further promote neuronal dysfunction and degeneration.

Similar articles

Cited by

References

    1. Kahle PJ. α-Synucleinopathy models and human neuropathology: similarities and differences. Acta Neuropathologica. 2008;115(1):87–95. - PubMed
    1. Gasser T. Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Reviews in Molecular Medicine. 2009;11, article e22 - PubMed
    1. Scholz SW, Houlden H, Schulte C, et al. SNCA variants are associated with increased risk for multiple system atrophy. Annals of Neurology. 2009;65(5):610–614. - PMC - PubMed
    1. Lippa CF, Duda JE, Grossman M, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 2007;68(11):812–819. - PubMed
    1. Baba M, Nakajo S, Tu PH, et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies. American Journal of Pathology. 1998;152(4):879–884. - PMC - PubMed

LinkOut - more resources